AzTrials
AzTrials

Concussion, BrainREMEMBRNCT06956417

REhabilitation of MEMory Symptoms After BRain Concussion

A study testing Cognitive behavioral therapy and Cognitive rehabilitation in people with Concussion, Brain and Mild Traumatic Brain Injury, run by University of British Columbia at 8 sites in Canada.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Persistent memory symptoms after concussion are common, and likely perpetuated by unhelpful illness beliefs and coping behaviors. Results from a pilot study suggested that traditional cognitive rehabilitation and a novel cognitive-behavioral therapy (CBT) protocol were both associated with improvements in subjective… Read more about this study

Who is it for?
Ages 18 to 59 years
What is being tested?
Cognitive behavioral therapy and Cognitive rehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
184 participants
Where
8 sitesCanada
Study dates
2 Jul 2025to 30 Apr 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 59 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Age 18-59
  • Concussion diagnosis confirmed with structured interview based on American Congress of Rehabilitation Medicine diagnostic criteria
  • Concussion occurred between 6 and 36 months before enrollment
  • Ongoing memory concerns
  • Fluent in English
  • Stable access to a computer, tablet, or smartphone with internet capability

Who cannot join

  • Fail performance validity testing
  • Comorbid psychiatric or neurological disorder or is taking a medication that could fully account for their memory symptoms

Trial locations and contacts

8 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Noah D Silverberg, PhD contact

6047341313 ext. 2316

noah.silverberg@ubc.ca

8 sites in 1 country

Canada8 sites, 7 recruiting
  • Calgary Brain Injury Program

    Calgary, Alberta, T2N 2T9

    Chantel Debert, chantel.debert@albertahealthservices.ca

    Christina Campbell, christina.campbel1@ucalgary.ca

    Recruiting
  • Integrated Adult Concussion Program at Hamilton Health Sciences

    Hamilton, Ontario, L8N 3Z5

    Active, not recruiting
  • Fraser Health Acquired Brain Injury and Concussion Services

    Langley, British Columbia, V1M 4A6

    William Panenka, will.panenka@ubc.ca

    Recruiting
  • 360 Concussion Care Clinic

    Ottawa, Ontario, K1H 7X7

    Roger Zemek, 1-613-668-0360, roger.zemek@360concussioncare.com

    Recruiting
  • Sunnybrook Traumatic Brain Injury Clinic

    Toronto, Ontario, M4N 3M5

    Matthew Burke, matthew.burke@sunnybrook.ca

    Recruiting
  • Hull-Ellis Concussion and Research Clinic at University Health Network

    Toronto, Ontario, M5G 2A2

    Mark Bayley, mark.bayley@uhn.ca

    Tharshini Chandra, (416) 597-3422 ext. 3645, tharshini.chandra@uhn.ca

    Recruiting
  • Canadian Concussion Centre at Toronto Western Hospital

    Toronto, Ontario, M5T 2S8

    Carmela Tartaglia, 416-603-5483, carmela.tartaglia@uhn.ca

    Artee Srivastava, Artee.Srivastava@uhn.ca

    Recruiting
  • G.F. Strong Adult Concussion Services

    Vancouver, British Columbia, V5Z 2G9

    Sarah Courtice, 604-734-4113, Sarah.Courtice@vch.ca

    Recruiting

Other trials in Canada

About this study

Persistent memory symptoms after concussion are common, and likely perpetuated by unhelpful illness beliefs and coping behaviors. Results from a pilot study suggested that traditional cognitive rehabilitation and a novel cognitive-behavioral therapy (CBT) protocol were both associated with improvements in subjective memory functioning. The present study will more definitively compare the effectiveness of these interventions for improving subjective memory functioning after concussion.

Read the detailed description

The primary research aims of this study are to determine whether cognitive behavioral therapy (CBT) and cognitive compensatory strategy training (CCST) improves subjective memory functioning compared to usual care, and to compare the effectiveness of CBT and CCST. This study is a multisite three-armed randomized control trial (RCT) that will randomize adults with persistent memory symptoms following concussion to CBT, CCST, or a covert waitlist condition (2:2:1). Participants will be blinded to the other arms of the study and the study hypotheses.

Being tested
Cognitive behavioral therapy, Cognitive rehabilitation
Keywords
Functional cognitive disorder
Medical subject headings
Brain Concussion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive behavioral therapyBehavioural

    Cognitive behavioral therapy (CBT) is delivered by a psychologist over 10 individual (1:1) manualized videoconference sessions. The goal of this therapy is for participants to use their memory more normally (i.e., reduce avoidance and safety behaviors) and view memory lapses as less threatening.

  • Cognitive rehabilitationBehavioural

    Cognitive compensatory strategy training (CCST), a traditional cognitive rehabilitation intervention, is delivered by a Occupational Therapist over 10 individual (1:1) manualized videoconference sessions. Participants optimize their use of current compensatory strategies and/or learn new ones suited to their needs and lifestyle. The goal is to minimize memory lapses in daily life.

Study groups in NCT06956417
Study groupRoleWhat they receive
Cognitive behavioral therapyExperimentalNot described
Receives: Behavioral: Cognitive behavioral therapy
Cognitive rehabilitationActive comparatorNot described
Receives: Behavioral: Cognitive rehabilitation
Waitlist - Usual careNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Multifactorial Memory Questionnaire-Satisfaction scale

    Measures participants' concern, satisfaction, and overall appraisal of their memory ability. Participants rate their agreement with 18 statements. Total scores range from 0 to 72, with lower total scores indicating worse subjective memory functioning.

    Measured: Week 20

Secondary outcomes (3)
  1. Fear-Avoidance of Memory Loss Scale

    Assesses fears and avoidance behaviors associated with memory decline. Participants rate 24 items on a 5-point scale, where the higher scores indicate greater memory concern and maladaptive coping.

    Measured: Week 1 and week 20

  2. Patient Global Impression of Change scale

    Participants rate how much their memory functioning has improved or declined overall since the beginning of the study, on a single item rated on a 7-point scale where the midpoint is no change.

    Measured: Week 20

  3. Work and Social Adjustment Scale

    Participants rate how much their condition interferes with their ability to carry out occupational and social activities across 5 items, on a scale from 1-7 where higher scores indicate more difficulty.

    Measured: Week 1 and week 20

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 May 2025
  2. Study start2 Jul 2025
  3. Primary completion30 Apr 2028 (estimated)
  4. Study completion30 Apr 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
184 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06956417
Sponsor's protocol ID
H24-02486
Acronym
REMEMBR
Status last verified
May 2026
First submitted
25 Apr 2025
Last updated
2 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Rioux M, Mamman R, Byworth MT, Panenka WJ, Howard AK, Perez DL, Schmidt J, Courchesne C, LeMoult J, Heran MK, Silverberg ND. Pilot feasibility randomised controlled trial of cognitive-behavioural therapy for functional cognitive disorder after concussion. BMJ Neurol Open. 2024 Oct 11;6(2):e000666. doi: 10.1136/bmjno-2024-000666. eCollection 2024.

    PubMed 39410977

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive behavioral therapy and Cognitive rehabilitation in people with Concussion, Brain and Mild Traumatic Brain Injury, run by University of British Columbia at 8 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 8 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Noah D Silverberg, PhD (6047341313 ext. 2316, noah.silverberg@ubc.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Multifactorial Memory Questionnaire-Satisfaction scale (time frame: Week 20). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06956417, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in